Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma (Q33305690)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
scientific article

    Statements

    Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma (English)
    Leah M Prentice
    Christian Klausen
    Steve Kalloger
    Martin Köbel
    Steven McKinney
    Jennifer L Santos
    Challayne Kenney
    Ken Swenerton
    David G Huntsman
    Samuel A J Aparicio
    15 November 2007

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit